Endothelin converting enzyme inhibitors
US5338726A · kind A · utility
20Cited by
2References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 29, 1992 |
| Grant date | Aug 16, 1994 |
| Priority date | — |
| Expiry date | Sep 29, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds are disclosed which inhibit endothelin converting enzyme. These compounds are useful for treating hypertension, congestive heart failure, myocardial infarction, reperfusion injury, coronary angina, cerebral vasospasm, acute renal failure, non-steroidal antiinflammatory drug induced gastric ulceration, cyclosporin induced nephrotoxicity, endotoxin-induced toxicity, asthma and atherosclerosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.